Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. - Wikidata - wikimedia - TriplyDB

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.

http://www.wikidata.org/entity/Q35169094

about

Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells When Prostate Cancer Circulates in the Bloodstream Epithelial-Mesenchymal Transition and Breast Cancer Circulating tumor cells in breast cancer Interaction between circulating cancer cells and platelets: clinical implication The role of EMT and MET in cancer dissemination Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers Dynamic changes in numbers and properties of circulating tumor cells and their potential applications Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer Detection of circulating tumor cells The role of Snail in prostate cancer Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Significance of circulating tumor cells in soft tissue sarcoma.Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back AKT-ions with a TWIST between EMT and MET Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer Actin cytoskeletal control during epithelial to mesenchymal transition: focus on the pancreas and intestinal tract Microfluidic cell sorting: a review of the advances in the separation of cells from debulking to rare cell isolation EMT, CTCs and CSCs in tumor relapse and drug-resistance Using circulating tumor cells to inform on prostate cancer biology and clinical utility Cellular Plasticity in Prostate Cancer Bone Metastasis CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.Application and Exploration of Big Data Mining in Clinical Medicine.Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease.Novel tools for prostate cancer prognosis, diagnosis, and follow-up Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells.

P2860

Q21284707-1B8A7F28-8CC6-4F36-994B-269D269C5ECD Q26739972-3033CD8C-B84D-4322-B79D-391C6D1F4EF4 Q26741223-E932BD35-FE68-4239-A178-78EEBF5C572B Q26748850-FEA1855C-29F0-427A-A2EB-BA0CFEDCA7F2 Q26768470-08D7F470-B21A-4E8A-BB48-626AA1CEDF8C Q26773055-05A68D71-7FC2-4263-83CF-B7CD1602C61A Q26774808-0FBA9545-1485-4FFC-9944-727710ABB5AA Q26778920-1DA8F870-77AB-4B48-931F-8E8739F4897D Q26796298-7EB1FDBA-1E97-40A9-9CB8-DF543C424CEB Q26799987-76A61A7D-E25D-45A2-BB3A-F0F1587C0FBF Q26822406-5C818A6B-248B-42CE-B55C-EAE11B7EE3EE Q26853569-F11735C2-4522-43A7-A026-987A577B87CE Q26858922-6E507DA3-BB3F-46C9-9C64-A572E2899F7F Q26859334-E13838AA-AAF4-4BCB-AE60-2B77F7B71BD5 Q27004557-38288E49-2BE7-4080-BDAC-C6F45F1056A9 Q27024191-7A434A97-CB42-4A72-AA23-42BC85678066 Q27693309-1D6D65D3-3716-4A9F-9A87-9D8133B841C6 Q28067549-9B12FA3E-8031-4624-A378-BDC407E610F5 Q28070333-F0A30AD9-240C-481C-BFFC-441316CA6F1D Q28078987-09A98556-5F98-41FB-B45F-FB0E63B9BF1E Q28079205-67D01E17-C8D7-4D67-A0C9-F9AA33BFCBBE Q28082719-4927632D-6DEB-42D3-9BCB-8FD5FD3D467B Q28082820-A29EC9A3-F229-441C-B48F-31FFF9271472 Q28082935-7F8534C7-57DD-4BEE-BD95-70D7EF70D6B6 Q28083261-0A3D8E93-CAC4-4212-B2E0-B67BE6F88E63 Q28085013-E6B11C8A-8E54-4331-9CFE-46F487A24710 Q28250164-EFB0ACCA-DF69-4B65-B4C1-27D4B5FB062B Q28484040-A8358E8D-0C56-4A80-BA14-20F0C0BB3402 Q29615853-D905C597-968E-4E04-BA54-9BB8E4D62806 Q30445250-B0C4D6BA-C984-44B7-9692-7D8283AC63AD Q31056142-231E1ED7-C9EC-4246-9218-140D84E97780 Q31118547-82F35570-9FAC-4855-B141-C656F54BDFB1 Q33405335-125E13A1-6014-4CA0-A300-9609D3BCFA45 Q33625338-5F5B2562-C5B5-4D66-B77A-25852904B287 Q33728631-757E9CB4-A3F7-4C87-A494-5A39FE36E173 Q33741201-513F5501-F03D-43C1-8CF7-A087AE8E6B97 Q33759701-BBE3A1BD-8739-4723-BBFA-3F0C975AC2EB Q33798322-B243684F-AE09-4B22-9E85-62615F0C4E22 Q33815087-E505316E-B03C-4772-82AF-09456CE536BF Q33869749-1711F3D9-C49C-4076-957E-30A76ADAE1D9

P2860

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.

http://www.wikidata.org/entity/Q35169094

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Circulating tumor cells from p ...... elial and mesenchymal markers.

@ast

Circulating tumor cells from p ...... elial and mesenchymal markers.

@en

type

label

Circulating tumor cells from p ...... elial and mesenchymal markers.

@ast

Circulating tumor cells from p ...... elial and mesenchymal markers.

@en

prefLabel

Circulating tumor cells from p ...... elial and mesenchymal markers.

@ast

Circulating tumor cells from p ...... elial and mesenchymal markers.

@en

P1433

Q35169094-73B7F252-0231-4D8C-B6F5-774DF305CF63

P1476

Q35169094-C5F6629A-0DCA-4DB9-86F8-CA7FCA79DEAE

P2093

Q35169094-05A7CCEC-31D6-433C-8595-DD9D4C407D86

Q35169094-0DD1D890-B1D2-4A1F-A060-88E2AC1E9009

Q35169094-4FA9DE17-CB7A-4773-A8B8-23DF967D652C

Q35169094-764CDA14-3039-45A5-A6AC-B9E3D68552A0

Q35169094-7B075B75-0FBD-4BC7-AED8-B29AC8E0AEF1

Q35169094-7B28E7C9-4FAF-4787-B601-F17A6DB0D4FE

Q35169094-7C989254-7D46-4E46-B63E-67E04A67DC9C

Q35169094-BA32AB03-F860-4D2F-836F-4719A4DD693F

Q35169094-EB907081-7981-4E1E-8769-8DC2E28C0AF4

Q35169094-FC7F0B23-247D-40AD-B53D-1E4549A8D8DE

P2860

Q35169094-043C5DD7-B5C4-44B5-A247-569C88AD008F

Q35169094-04A84921-FB5E-4F2A-A372-6C3856D03091

Q35169094-1A201B4E-AAD1-4399-9028-F3025168BD4B

Q35169094-2651350A-9C5B-4969-90B8-0685CD7CF8D1

Q35169094-30746399-89DE-433A-BCD5-2E0B211FB7F6

Q35169094-31C86C51-23C1-4AC8-B8E2-E7305DFA178A

Q35169094-32273DEE-2330-4935-9605-BDC0E768754F

Q35169094-34BCD808-C6A8-4DF2-825A-01852914A068

Q35169094-36B8D529-9974-4498-811B-30282722F458

Q35169094-46123548-209E-4B03-891A-96FCA6723748

P304

Q35169094-18CCA90D-4C6F-417F-AAB6-6B8AB5194F4A

P31

Q35169094-AFCA322F-49F0-40C8-A784-48492A09B594

P356

Q35169094-ABE8F2E8-2DF1-4718-855F-F28089BB7D6D

P433

Q35169094-63F19825-295F-4F75-BAB8-4D7C889AF66B

P478

Q35169094-E3F7E2C0-517D-46D8-B5E7-F0090BC3D025

P577

Q35169094-35339476-2DCA-4C48-BABE-BEC59ACFC6CC

P698

Q35169094-3D09D6DE-96A1-4F89-A502-806CA149F0A8

P932

Q35169094-438978E7-B5A6-49D8-BA43-914951B5C7A1

P356

1541-7786.MCR-10-0490

P1433

Molecular Cancer Research

P1476

Circulating tumor cells from p ...... elial and mesenchymal markers.

@en

P2093

Andrew J Armstrong

http://www.w3.org/2001/XMLSchema#string

Christina I Herold

http://www.w3.org/2001/XMLSchema#string

Daniel J George

http://www.w3.org/2001/XMLSchema#string

Gabor Kemeny

http://www.w3.org/2001/XMLSchema#string

James D Turnbull

http://www.w3.org/2001/XMLSchema#string

Mariano A Garcia-Blanco

http://www.w3.org/2001/XMLSchema#string

Matthew S Marengo

http://www.w3.org/2001/XMLSchema#string

Paul K Marcom

http://www.w3.org/2001/XMLSchema#string

Rhonda L Bitting

http://www.w3.org/2001/XMLSchema#string

Sebastian Oltean

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

Identification and expansion of human colon-cancer-initiating cells

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

Identification of selective inhibitors of cancer stem cells by high-throughput screening

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

P304

997-1007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-10-0490

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21665936

http://www.w3.org/2001/XMLSchema#string

P932

3157566

http://www.w3.org/2001/XMLSchema#string